Therapeutic Areas of Interest | Chiesi Australia Pty Ltd

Air

Chiesi has been developing medicines to treat respiratory disease for more than 30 years. Thanks to modern treatments, patients with asthma or chronic obstructive pulmonary disease (COPD) have a better chance to live more active lives.

Care

Any child born before the 37th week of pregnancy is deemed to be premature. Thanks to the enormous progress in neonatology, which is a branch of paediatrics, even children who come into this world early now have a good chance of a healthy life.

Rare

A rare disease is a term used for any disease that affects less than 5 in 10,000 people. To date, between 6000 and 8000 rare diseases have been discovered and new diseases are regularly described in medical literature. Approximately 80% of rare diseases are of genetic origin.

CHIESI ON THE WEB

Australia

Chiesi Australia Pty Ltd

Austria

Chiesi Pharmaceuticals GmbH

Belgium

Chiesi sa

Brazil

Chiesi Farmacêutica Ltda

Bulgaria

Chiesi Bulgaria Ltd.

China

Chiesi Pharmaceutical (Shanghai) Co., Ltd

Czech Republic

Chiesi CZ s.r.o.

France

Chiesi S.A.

Germany

Chiesi GmbH

Greece

Chiesi Hellas Pharmaceuticals S.A.

Hungary

Chiesi Hungary Kft.

Italy

Divisione Farmaceutica Italia

Mexico

Chiesi Mexico S.A. de C.V.

Pakistan

Chiesi Pharmaceuticals (Pvt) Limited

Poland

Chiesi Polonia

Romania

Chiesi România S.r.l.

Russian Federetion

Chiesi Pharmaceuticals LLC

Slovak Republic

Chiesi Slovakia s.r.o

Slovenia

Chiesi Slovenija, d.o.o

Spain

Chiesi España S.A.

Sweden

Chiesi Pharma AB

The Netherlands

Chiesi Pharmaceuticals B.V.

Turkey

Chiesi Ä°laçTicaret Limited Sirketi A.Åž.

United Kingdom

Chiesi Ltd

United States

Chiesi Usa Inc.